Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study

Primary mediastinal large B-cell lymphoma (PMLBL) is a rare entity predominantly affecting adolescents and young adults. Recently, an international phase II trial in pediatric patients using dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone plus rituximab (DA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dourthe, Marie Emilie, Phulpin, Aurélie, Auperin, Anne, Bosq, Jacques, Couec, Marie-Laure, Dartigues, Peggy, Ducassou, Stéphane, Garnier, Nathalie, Haouy, Stéphanie, Leblanc, Thierry, Leruste, Amaury, Paillard, Catherine, Rigaud, Charlotte, Simonin, Mathieu, Patte, Catherine, Minard-Colin, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Non-Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425314/
https://www.ncbi.nlm.nih.gov/pubmed/35236054
http://dx.doi.org/10.3324/haematol.2021.280257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425314/
https://www.ncbi.nlm.nih.gov/pubmed/35236054
http://dx.doi.org/10.3324/haematol.2021.280257

Ejemplares similares